Hunan Aslsen Technology: difference between revisions
Diff·revision 28 → 29·20:04, 2 Mar 2025
Difference between revision 28 and revision 29 of Hunan Aslsen Technology. 5 lines changed; the page grew by 673 bytes.
| Revision 28 — 07:40, 21 Feb 2025 EpitalonEoin (talk) attribute claim in-text 6,326 bytes ±0 | Revision 29 — 20:04, 2 Mar 2025 SourceHunterSile (talk) attribute claim in-text 6,999 bytes +673 | ||
|---|---|---|---|
| 48 | The catalogue is narrower than most covered here. Documentation in the submitted set has been consistently thin, without the peptide-versus-bulk gradient visible elsewhere.{{r|reports}} | 48 | The catalogue is narrower than most covered here. Documentation in the submitted set has been consistently thin, without the peptide-versus-bulk gradient visible elsewhere.{{r|reports}} |
| 49 | 49 | ||
| + | 50 | == Independent testing record == | |
| + | 51 | Submitted reports on Homopeptide material to July 2026 span the incretin range and a set of SARMs. Reported [[Area percent purity|area percent]] figures have been more dispersed than for the better-documented entities, with a visible proportion below the high-nineties cluster.{{r|reports}} | |
| + | 52 | ||
| + | 53 | Two limitations compound here. Without a method statement on the certificate, a disagreement between certificate and report cannot be attributed to the material or to the separation. Without a water figure, no reported purity can be converted into a mass. The reports therefore constrain the material less than their number suggests.{{r|usp1503}} | |
| + | 54 | ||
| 50 | == References == | 55 | == References == |
| 51 | {{reflist}} | 56 | {{reflist}} |